An imbalance between inhibitors of vascular calcification (such as fetuin-A and matrix Gla protein) and stimulators of calcification (hyperphosphatemia, elevated serum calcium-phosphate product) as well as leptin may play an essential role in increasing the risk of valvular disease and atherosclerosis (25). Here, LEP is linked to hyperphosphatemia.